TNNI3 and cancer: To date, PGM has been adapted and is popular for medical purposes, for example, for the quantitative determination of several protein biomarkers in blood serum, including antibodies to digoxin, thrombin, and antibodies to hepatitis C virus [102], cancer cells [103], cardiac troponin I [104], cancer biomarkers [105,106], atherosclerosis biomarkers [107], biomarkers of Alzheimer’s disease [108], screening for kinase-targeting drugs [109], and mRNA for disease diagnosis [103].